5.65%GE 20.37 5.56%QQQQ 34.01 6.00%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
PALATINE, Ill. - Acura Pharmaceuticals Inc. said Monday it received a $5 million milestone payment from King Pharmaceuticals Inc. for meeting the main goals of a late-stage study on pain relief drug Acurox.
Acurox tablets contain the opioid oxycodone HCl, niacin and several functional inactive ingredients. The drug is designed to relieve pain while deterring prescription drug abuse.
Under an agreement signed in October, King Pharmaceuticals Inc. has a license to market the drug. An Acurox application is expected to be submitted to the Food and Drug Administration for approval by the end of the year.
The Obama campaign launched a campaign ad, short documentary and web site attacking Republican presidential nominee John McCain's judgment a...
Vice presidential debate surveys after Thursday's debate overall show Gov. Sarah Palin lost the debate with Sen. Joe Biden. But why a loss a...
Republicans John McCain and Sarah Palin on Friday played up her debate performan...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
0.02
-0.69
